Jin K, Ma Z, Zhao C, Zhou X, Xu H, Li D
Sci Rep. 2025; 15(1):6128.
PMID: 39972065
PMC: 11839988.
DOI: 10.1038/s41598-025-90816-4.
Qu S, Zhang Z, Ju R, Li Z, Leng J, Xue Z
BMC Public Health. 2024; 24(1):3578.
PMID: 39719571
PMC: 11667859.
DOI: 10.1186/s12889-024-21001-x.
Meng H, Zhou X, Li L, Liu Y, Liu Y, Zhang Y
Sci Rep. 2024; 14(1):30175.
PMID: 39632977
PMC: 11618658.
DOI: 10.1038/s41598-024-81818-9.
Wu H, Yang G, Zhang S, Luo J, Zhou P, Chen Y
Int J Gen Med. 2024; 17:4607-4615.
PMID: 39429962
PMC: 11488507.
DOI: 10.2147/IJGM.S475008.
Chen Y, Wang Y, Chen F, Chen C, Dong X
Rev Cardiovasc Med. 2024; 25(8):275.
PMID: 39228488
PMC: 11367012.
DOI: 10.31083/j.rcm2508275.
Association between diabetes mellitus and primary restenosis following endovascular treatment: a comprehensive meta-analysis of randomized controlled trials.
Sun X, Zhang C, Ma Y, He Y, Zhang X, Wu J
Cardiovasc Diabetol. 2024; 23(1):132.
PMID: 38650038
PMC: 11036687.
DOI: 10.1186/s12933-024-02201-6.
Frailty efficacy as a predictor of clinical and cognitive complications in patients undergoing coronary artery bypass grafting: a prospective cohort study.
Bakhtiari M, Shaker F, Ojaghi Shirmard F, Jalali A, Vakili-Basir A, Balabandian M
BMC Cardiovasc Disord. 2024; 24(1):110.
PMID: 38365571
PMC: 10874082.
DOI: 10.1186/s12872-024-03781-7.
Coronary artery disease incidence, risk factors, awareness, and medication utilization in a 10-year cohort study.
Sarebanhassanabadi M, Reza Mirjalili S, Marques-Vidal P, Kraemer A, Namayandeh S
BMC Cardiovasc Disord. 2024; 24(1):101.
PMID: 38347457
PMC: 10863377.
DOI: 10.1186/s12872-024-03769-3.
Complete or Culprit-Only PCI in Older Patients with MI.
Mone P, Guerra G, Santulli G
N Engl J Med. 2023; 389(20):1923-1924.
PMID: 37966296
PMC: 11388172.
DOI: 10.1056/NEJMc2311551.
Association between admission-blood-glucose-to-albumin ratio and clinical outcomes in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention.
Zhen C, Chen W, Chen W, Fan H, Lin Z, Zeng L
Front Cardiovasc Med. 2023; 10:1132685.
PMID: 37745131
PMC: 10513433.
DOI: 10.3389/fcvm.2023.1132685.
Association of cyclophilins and cardiovascular risk factors in coronary artery disease.
Gegunde S, Alfonso A, Alvarino R, Perez-Fuentes N, Bayon-Lorenzo J, Alonso E
Front Physiol. 2023; 14:1127468.
PMID: 36935755
PMC: 10014534.
DOI: 10.3389/fphys.2023.1127468.
SGLT-2 inhibitors and in-stent restenosis-related events after acute myocardial infarction: an observational study in patients with type 2 diabetes.
Marfella R, Sardu C, DOnofrio N, Fumagalli C, Scisciola L, Sasso F
BMC Med. 2023; 21(1):71.
PMID: 36829203
PMC: 9960194.
DOI: 10.1186/s12916-023-02781-2.
Hyperglycemia drives the transition from pre-frailty to frailty: The Monteforte study.
Mone P, De Gennaro S, Frullone S, Marro A, Santulli G
Eur J Intern Med. 2023; 111:135-137.
PMID: 36635128
PMC: 10122706.
DOI: 10.1016/j.ejim.2023.01.006.
Stress Hyperglycemia Drives the Risk of Hospitalization for Chest Pain in Patients With Ischemia and Nonobstructive Coronary Arteries (INOCA).
Mone P, Lombardi A, Salemme L, Cioppa A, Popusoi G, Varzideh F
Diabetes Care. 2022; 46(2):450-454.
PMID: 36478189
PMC: 9887616.
DOI: 10.2337/dc22-0783.
Analysis of the incidence and influencing factors associated with binary restenosis of target lesions after drug-coated balloon angioplasty for patients with in-stent restenosis.
Xue W, Ma J, Yu X, Ruan Z, Sun Y, Wu T
BMC Cardiovasc Disord. 2022; 22(1):493.
PMID: 36404303
PMC: 9677633.
DOI: 10.1186/s12872-022-02923-z.
Correlation between Carbonic Anhydrase Isozymes and the Evolution of Myocardial Infarction in Diabetic Patients.
Magheru S, Magheru C, Maghiar F, Sachelarie L, Marc F, Moldovan C
Biology (Basel). 2022; 11(8).
PMID: 36009816
PMC: 9404923.
DOI: 10.3390/biology11081189.
Metabolic signatures of insulin resistance in non-diabetic individuals.
Arjmand B, Fana S, Ghasemi E, Kazemi A, Ghodssi-Ghassemabadi R, Dehghanbanadaki H
BMC Endocr Disord. 2022; 22(1):212.
PMID: 36002887
PMC: 9404631.
DOI: 10.1186/s12902-022-01130-3.
Assessment of Trimetazidine Treatment in Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention.
Tang X, Gong J
Cardiol Res Pract. 2022; 2022:7674366.
PMID: 35818572
PMC: 9270998.
DOI: 10.1155/2022/7674366.
SGLT2 Inhibition via Empagliflozin Improves Endothelial Function and Reduces Mitochondrial Oxidative Stress: Insights From Frail Hypertensive and Diabetic Patients.
Mone P, Varzideh F, Jankauskas S, Pansini A, Lombardi A, Frullone S
Hypertension. 2022; 79(8):1633-1643.
PMID: 35703100
PMC: 9642044.
DOI: 10.1161/HYPERTENSIONAHA.122.19586.
Hyperglycemia and Physical Impairment in Frail Hypertensive Older Adults.
Pansini A, Lombardi A, Morgante M, Frullone S, Marro A, Rizzo M
Front Endocrinol (Lausanne). 2022; 13:831556.
PMID: 35498439
PMC: 9048203.
DOI: 10.3389/fendo.2022.831556.
